Miyuki Akutsu

1.4k total citations
40 papers, 1.2k citations indexed

About

Miyuki Akutsu is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Miyuki Akutsu has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 18 papers in Molecular Biology and 10 papers in Hematology. Recurrent topics in Miyuki Akutsu's work include Cancer Treatment and Pharmacology (13 papers), Cancer therapeutics and mechanisms (13 papers) and Acute Lymphoblastic Leukemia research (8 papers). Miyuki Akutsu is often cited by papers focused on Cancer Treatment and Pharmacology (13 papers), Cancer therapeutics and mechanisms (13 papers) and Acute Lymphoblastic Leukemia research (8 papers). Miyuki Akutsu collaborates with scholars based in Japan and United States. Miyuki Akutsu's co-authors include Yasuhiko Kano, Yusuke Furukawa, Kenichi Suzuki, Saburo Tsunoda, Hiroyuki Mano, Yasusada Miura, Yuko Sato, Shinobu Sakamoto, Yoshio Honma and Shin‐ichi Tsunoda and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Miyuki Akutsu

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miyuki Akutsu Japan 18 622 516 403 256 157 40 1.2k
Steven Novick United States 16 819 1.3× 437 0.8× 645 1.6× 362 1.4× 131 0.8× 28 1.4k
Chetasi Talati United States 16 512 0.8× 247 0.5× 592 1.5× 326 1.3× 96 0.6× 78 1.1k
Zhenghong Peng United States 15 526 0.8× 238 0.5× 265 0.7× 185 0.7× 106 0.7× 38 1.0k
Anne Blackwood‐Chirchir United States 12 241 0.4× 475 0.9× 414 1.0× 366 1.4× 210 1.3× 22 1.0k
Nicholas Lea United Kingdom 19 691 1.1× 228 0.4× 832 2.1× 516 2.0× 89 0.6× 40 1.6k
Peter Bross United States 8 686 1.1× 600 1.2× 464 1.2× 132 0.5× 80 0.5× 14 1.4k
Benjamin D. Hedley Canada 16 464 0.7× 544 1.1× 190 0.5× 93 0.4× 104 0.7× 40 1.1k
Fabien Calvo France 7 761 1.2× 345 0.7× 167 0.4× 110 0.4× 199 1.3× 13 1.4k
Z Estrov United States 15 335 0.5× 287 0.6× 631 1.6× 330 1.3× 45 0.3× 17 1.1k

Countries citing papers authored by Miyuki Akutsu

Since Specialization
Citations

This map shows the geographic impact of Miyuki Akutsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miyuki Akutsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miyuki Akutsu more than expected).

Fields of papers citing papers by Miyuki Akutsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miyuki Akutsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miyuki Akutsu. The network helps show where Miyuki Akutsu may publish in the future.

Co-authorship network of co-authors of Miyuki Akutsu

This figure shows the co-authorship network connecting the top 25 collaborators of Miyuki Akutsu. A scholar is included among the top collaborators of Miyuki Akutsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miyuki Akutsu. Miyuki Akutsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hiraoka, Nobuya, Jiro Kikuchi, Takahiro Yamauchi, et al.. (2014). Purine Analog-Like Properties of Bendamustine Underlie Rapid Activation of DNA Damage Response and Synergistic Effects with Pyrimidine Analogues in Lymphoid Malignancies. PLoS ONE. 9(3). e90675–e90675. 21 indexed citations
2.
Kikuchi, Jiro, Satoshi Yamada, Daisuke Koyama, et al.. (2013). The Novel Orally Active Proteasome Inhibitor K-7174 Exerts Anti-myeloma Activity in Vitro and in Vivo by Down-regulating the Expression of Class I Histone Deacetylases. Journal of Biological Chemistry. 288(35). 25593–25602. 24 indexed citations
3.
Akutsu, Miyuki, Saburo Tsunoda, Tohru Izumi, et al.. (2008). Long-Term Results of Dose-Intensive Chemotherapy With G-CSF Support (TCC-NHL-91) for Advanced Intermediate-Grade Non-Hodgkin's Lymphoma: A Review of 59 Consecutive Cases Treated at a Single Institute. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 17(3). 137–149. 2 indexed citations
4.
Kano, Yasuhiko, Miyuki Akutsu, Saburo Tsunoda, et al.. (2004). Schedule-dependent synergism and antagonism between pemetrexed and paclitaxel in human carcinoma cell lines in vitro. Cancer Chemotherapy and Pharmacology. 54(6). 505–513. 14 indexed citations
5.
Akutsu, Miyuki, Yusuke Furukawa, Shin‐ichi Tsunoda, et al.. (2002). Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro. Leukemia. 16(9). 1808–1817. 24 indexed citations
6.
Ota, Jun, Masuzu Ueda, Shuichi Ueno, et al.. (2001). Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells. Oncogene. 20(57). 8249–8257. 67 indexed citations
7.
Akutsu, Miyuki, et al.. (2001). [Late phase II clinical study of amrubicin hydrochloride, a novel synthetic anthracycline derivative anticancer agent, for malignant lymphoma].. PubMed. 28(12). 1867–76. 3 indexed citations
8.
Kano, Yasuhiko, Miyuki Akutsu, Shin‐ichi Tsunoda, et al.. (2000). In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis. Leukemia. 14(3). 379–388. 27 indexed citations
9.
Kano, Yasuhiko, Miyuki Akutsu, Kenichi Suzuki, Yasuo Yazawa, & Saburo Tsunoda. (2000). Schedule‐dependent Interactions between Raltitrexed and Cisplatin in Human Carcinoma Cell Lines in vitro. Japanese Journal of Cancer Research. 91(4). 424–432. 2 indexed citations
10.
Kano, Yasuhiko, Miyuki Akutsu, Kenichi Suzuki, et al.. (1999). Schedule-dependent interactions between paclitaxel and etoposide in human carcinoma cell lines in vitro. Cancer Chemotherapy and Pharmacology. 44(5). 381–388. 7 indexed citations
11.
Kano, Yasuhiko, et al.. (1998). In vitro schedule-dependent interaction between paclitaxel and SN-38 (the active metabolite of irinotecan) in human carcinoma cell lines. Cancer Chemotherapy and Pharmacology. 42(2). 91–98. 56 indexed citations
12.
Kano, Yasuhiko, et al.. (1998). Schedule-dependent synergism and antagonism between paclitaxel and methotrexate in human carcinoma cell lines.. PubMed. 10(7). 347–54. 15 indexed citations
13.
Yokoi, Kohei, Naoto Miyazawa, Yasuhiko Kano, et al.. (1997). Tumor Lysis Syndrome in Invasive Thymoma with Peripheral Blood T-Cell Lymphocytosis. American Journal of Clinical Oncology. 20(1). 86–89. 18 indexed citations
14.
Kano, Yasuhiko, Miyuki Akutsu, Shin‐ichi Tsunoda, et al.. (1996). Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro. British Journal of Cancer. 74(5). 704–710. 71 indexed citations
15.
Kano, Yasuhiko, Miyuki Akutsu, Kenichi Suzuki, & Minoru Yoshida. (1993). Effects of carboplatin in combination with other anticancer agents on human leukemia cell lines. Leukemia Research. 17(2). 113–119. 28 indexed citations
16.
Kano, Yasuhiko, Tetsuharu Narita, Kenichi Suzuki, et al.. (1992). The effects of ICRF-154 in combination with other anticancer agents in vitro. British Journal of Cancer. 66(2). 281–286. 15 indexed citations
17.
Kano, Yasuhiko, et al.. (1992). Effects of CPT‐11 in combination with other anti‐cancer agents in culture. International Journal of Cancer. 50(4). 604–610. 199 indexed citations
18.
Kano, Yasuhiko, et al.. (1991). Schedule-dependent synergism and antagonism between methotrexate and 6-mercaptopurine in a human acute lymphoblastic cell line. European Journal of Cancer and Clinical Oncology. 27(9). 1141–1145. 2 indexed citations
19.
Ema, Hideo, Toshio Suda, Hiromitsu Nakauchi, et al.. (1991). Multipotent and Committed CD34+ Cells in Bone Marrow Transplantation. Japanese Journal of Cancer Research. 82(5). 547–552. 4 indexed citations
20.
Furukawa, Yusuke, Miyuki Akutsu, Minoru Yoshida, et al.. (1988). Primary non-Hodgkin's lymphoma, small lymphocytic type, in the spleen complicating myelodysplastic syndrome.. Nihon Naika Gakkai Zasshi. 77(7). 1051–1055. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven Novick Breakdown of academic impact, for papers by Chetasi Talati Breakdown of academic impact, for papers by Zhenghong Peng Breakdown of academic impact, for papers by Anne Blackwood‐Chirchir Breakdown of academic impact, for papers by Nicholas Lea Breakdown of academic impact, for papers by Peter Bross Breakdown of academic impact, for papers by Benjamin D. Hedley Breakdown of academic impact, for papers by Fabien Calvo Breakdown of academic impact, for papers by Z Estrov
Rankless by CCL
2026